Automated outreach for helping cancer patients quit tobacco
Connect Cancer Patients to Tobacco Cessation Care by Automated Interactive Outreach
NA · University of California, San Francisco · NCT05829824
This study is testing if an automated program called CareConnect can help cancer patients quit smoking by providing support and resources.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 400 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of California, San Francisco (other) |
| Locations | 1 site (San Francisco, California) |
| Trial ID | NCT05829824 on ClinicalTrials.gov |
What this trial studies
This pilot study aims to evaluate the effectiveness of CareConnect, an automated interactive outreach program designed to assist cancer patients in quitting tobacco. Participants will be randomly assigned to either the intervention group, receiving CareConnect's support, or a control group. The study will assess the efficacy of referrals to tobacco cessation resources, patient acceptance of these referrals, and the overall acceptability of the CareConnect program. Additionally, qualitative interviews will be conducted with selected participants to gather in-depth insights into their experiences.
Who should consider this trial
Good fit: Ideal candidates are cancer patients aged 18 and older who currently use tobacco and have been seen by a UCSF Cancer Center-affiliated provider within the last three months.
Not a fit: Patients who are currently hospitalized or have been discharged from an inpatient setting within the past month may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve smoking cessation rates among cancer patients, enhancing their overall health outcomes.
How similar studies have performed: Other studies have shown promise in using automated interventions for smoking cessation, indicating that this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 18 years and older. 2. Able to understand study procedures and to comply with them for the entire length of the study. 3. Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it. 4. English, Spanish, Cantonese, or Mandarin speaking. 5. Self-reported current use of tobacco, including e-cigarette on EHR. 6. Has a diagnosis of cancer. 7. Has been seen by a prescribing provider within a UCSF Cancer Center-affiliated clinical department within the past 3 months. Exclusion Criteria: 1. Contraindication to any study-related procedure or assessment. 2. No valid contact telephone number. 3. Currently hospitalized or having been discharged from inpatient setting within the past month (according to EHR).
Where this trial is running
San Francisco, California
- University of California, San Francisco — San Francisco, California, United States (RECRUITING)
Study contacts
- Principal investigator: Janice Tsoh, PhD — University of California, San Francisco
- Study coordinator: Edgar Yu
- Email: Edgar.Yu@ucsf.edu
- Phone: 877-827-3222
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cancer, Tobacco Dependence, Tobacco Use Cessation, Interactive Intervention